Literature DB >> 8055151

Effects of tumour necrosis factor alpha and interleukin 1 beta on the proliferation of cultured glomerular epithelial cells.

M Yanagisawa1, H Imai, Y Fukushima, T Yasuda, A B Miura, Y Nakamoto.   

Abstract

Rat glomerular epithelial cells were cultured with human monocyte supernatant or with recombinant cytokines. A primary glomerular culture and a glomerular epithelial cell culture were made; supernatant from monocyte cultures derived from healthy humans, and recombinant tumour necrosis factor alpha (TNF alpha) or recombinant interleukin 1 beta (IL-1 beta) were added. Cell proliferation rates were assayed by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay. In serum-free media, consistent proliferation of glomerular epithelial cells (GEC) was observed throughout the 3 week culture period. Significant growth-stimulatory effects were induced by lipopolysaccharide-treated monocyte conditioned medium and by 1-50 ng/ml of TNF alpha, growth being up to 400% more than in the control culture. The effect of TNF alpha depended mainly on its interaction with epidermal growth factor (EGF). In contrast to TNF alpha, IL-1 beta inhibited GEC proliferation; this was due to the early appearance and proliferation of mesangial cells, despite the culture being serum-free. This study showed that activated monocytes secrete growth factors for GEC in vitro, and that interaction between both TNF alpha and IL-1 beta and between TNF alpha and EGF can modulate GEC proliferation. These findings suggest that, under pathological conditions, monocytes or macrophages affect GEC proliferation, probably being involved in crescent formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055151     DOI: 10.1007/bf00195770

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  32 in total

1.  Modulation of collagen synthesis in human glomerular epithelial cells by interleukin 1.

Authors:  I Torbohm; B Berger; M Schönermark; J von Kempis; K Rother; G M Hänsch
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

Review 2.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 3.  Immunopathogenesis of crescentic glomerulonephritis and lung purpura.

Authors:  D J Salant
Journal:  Kidney Int       Date:  1987-09       Impact factor: 10.612

4.  Kidney glomerular explants in serum-free media. Sequential morphologic and quantitative analysis of cell outgrowths.

Authors:  T D Oberley; B W Steinert; A H Yang; P J Anderson
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

5.  Cellular composition of crescents in human rapidly progressive glomerulonephritis identified using monoclonal antibodies.

Authors:  W W Hancock; R C Atkins
Journal:  Am J Nephrol       Date:  1984       Impact factor: 3.754

6.  Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.

Authors:  D T Vistica; P Skehan; D Scudiero; A Monks; A Pittman; M R Boyd
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

7.  Rat glomerular epithelial cells in culture. Parietal or visceral epithelial origin?

Authors:  J O Nørgaard
Journal:  Lab Invest       Date:  1987-09       Impact factor: 5.662

Review 8.  Cell culture approaches to the analysis of glomerular inflammation.

Authors:  D H Lovett; R B Sterzel
Journal:  Kidney Int       Date:  1986-08       Impact factor: 10.612

9.  Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts.

Authors:  V J Palombella; D J Yamashiro; F R Maxfield; S J Decker; J Vilcek
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

10.  Glomerular monocyte infiltration in human nephropathies: prevalence and correlation with clinical and morphological variables.

Authors:  G Monga; G Mazzucco; R Castello
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
View more
  7 in total

1.  Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats.

Authors:  C Braumann; J Ordemann; P Wildbrett; C A Jacobi
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.

Authors:  Chris Braumann; Marco Schoenbeck; Charalambos Menenakos; Maik Kilian; Christoph A Jacobi
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model.

Authors:  I Opitz; H C van der Veen; C Braumann; B Ablassmaier; K Führer; C A Jacobi
Journal:  Surg Endosc       Date:  2003-04-28       Impact factor: 4.584

4.  Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?

Authors:  G Rostoker; J C Rymer; G Bagnard; M Petit-Phar; M Griuncelli; Y Pilatte
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

5.  Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.

Authors:  Chris Braumann; Jürgen Ordemann; Maik Kilian; Frank A Wenger; Christoph A Jacobi
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case.

Authors:  Chris Braumann; Goetz Winkler; Patrick Rogalla; Charalambos Menenakos; Christoph A Jacobi
Journal:  World J Surg Oncol       Date:  2006-06-24       Impact factor: 2.754

7.  Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.

Authors:  Guanhong Li; Wei Wu; Xinyao Zhang; Yuan Huang; Yubing Wen; Xuemei Li; Ruitong Gao
Journal:  BMC Nephrol       Date:  2018-11-14       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.